Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000292002 | SCV000387963 | likely benign | Retinitis Pigmentosa, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001000291 | SCV001156942 | benign | Leber congenital amaurosis 13 | 2023-11-11 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001109348 | SCV001266675 | likely benign | Retinitis pigmentosa | 2018-01-15 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Invitae | RCV001000291 | SCV001719096 | benign | Leber congenital amaurosis 13 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001000291 | SCV001750145 | benign | Leber congenital amaurosis 13 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001683261 | SCV001899540 | benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27939946) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001805013 | SCV002050738 | likely benign | not specified | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888727 | SCV004707753 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Natera, |
RCV001277205 | SCV001464104 | benign | Leber congenital amaurosis | 2020-09-16 | no assertion criteria provided | clinical testing |